Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy.
about
The role of preoperative systemic treatment in patients with breast cancerNeoadjuvant therapy in the treatment of breast cancerSelective elimination of breast cancer surgery in exceptional responders: historical perspective and current trialsEfficacy and safety of dose-dense chemotherapy in urothelial carcinoma.Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapyIntratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657).Genome-driven integrated classification of breast cancer validated in over 7,500 samples.Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection.Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapyCan positron emission tomography/computed tomography with the dual tracers fluorine-18 fluoroestradiol and fluorodeoxyglucose predict neoadjuvant chemotherapy response of breast cancer?--A pilot study.Role of plasma osteopontin as a biomarker in locally advanced breast cancerEffect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis.Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled TrialsEfficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials.Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapyUsing the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and MastectomyComparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG.A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22.Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical OutcomePathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice.Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.Breast-conserving Surgery Rates in Breast Cancer Patients With Different Molecular Subtypes: An Observational Study Based on Surveillance, Epidemiology, and End Results (SEER) Database.Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.Effects of Neoadjuvant Chemotherapy on Benign Breast Lesions Compared to Cancers: Should an Additional Lesion on Magnetic Resonance Imaging Responding Similar to Cancer after Neoadjuvant Chemotherapy be Viewed with Suspicion?Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neChanges in chemotherapy usage and outcome of early breast cancer patients in the last decade.Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer.Impact of radiation therapy on survival in patients with triple-negative breast cancer.Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.Reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients.Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response.Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period
P2860
Q26746034-A0C42AAA-D5BE-4782-B437-CD9576CE03D0Q27694514-1687D86D-407A-4DD7-A054-1E1F1D4ED6BBQ28072923-0B94CD00-D5CF-4FD1-B4CA-6261D04489A9Q33441139-8496FEA3-4ED5-4F07-9F9B-6779A5C65ADFQ33573055-3CDB30A4-8D19-4749-AED4-0790D56D3108Q33706962-5B404923-A992-4350-A18F-08847E852D79Q33900807-AAFF0876-7B1A-46E9-BE67-C4978438093CQ33913615-A6DCBF41-EFF9-4E67-B501-4D46D321B07EQ34199428-D0A24CE4-336D-4DBD-995A-8EBEDBEAD2F5Q34316969-616F78D4-B499-405D-B439-4FE2E32CC1EEQ34501788-40AC8EBF-CE9A-45A1-A091-5A5123094A29Q35036174-1E4C2E8B-95BA-47D5-A177-7E4BE30F08B2Q35682597-DD8D5DE1-C71D-4BC7-9BC4-D198B7F7CCDCQ35759050-CB418D4B-750C-4BF8-A964-C5B5C0FBD968Q35789363-57F87D4F-A847-4412-8040-BB580CDB8F87Q35881780-1DAEEF35-43CC-48DF-A803-2719566BBEC9Q35954081-721218B5-D83A-4DE8-B77B-97E0B19E3861Q35981180-9C83F18A-8946-4EC8-8016-A93AE3C8BC92Q36187097-29428AEE-AFA7-4D03-BF0E-318394A26027Q36214778-C86E45ED-6F13-4AC4-91F8-AF22D6BD38CDQ36234011-B0FFDBAB-9D1D-4B5B-8670-95638DD4CBD9Q36286709-0E6DB533-3BE2-488C-83D5-F73BCCF30679Q36482428-F5BC10AD-0446-4FB5-A970-325274DED859Q36525431-24B9568C-8B1E-4A9C-97B9-CF5C22E180FEQ36546612-A4C40712-C939-49C5-A44B-8CAEC518A671Q36584124-71AE90F0-3CCC-4270-A8A5-3AF560978C43Q36653521-2F38C148-5C81-498C-94A5-58F6E16F0081Q36731328-2BDAE493-68BD-4064-9B6C-3B90EB6361CBQ36866538-B7719B71-8804-4676-9CC3-CFC5E23104BAQ36917231-374FFF1F-7537-4839-AE62-2C303F746ECDQ37294616-F76E6CE6-6F47-4413-8C7F-0AC13DD0A0A7Q37302415-9B7E9BBB-63ED-47E3-AA3C-EF106AED3DA1Q37385681-DDE5C2E4-B2B7-44DB-84CB-18AFD2E7D054Q37415526-6EB2D450-072A-4A79-A63B-5403D2A20E07Q37438041-9C9AB9C9-E49F-4C46-A892-D6CEE001A9C3Q37457684-EAA1BCD5-4427-4A2D-A457-D3FCFC5AFECDQ37484630-C699E85C-CE61-423F-B5F2-AC521A5BCD95Q37484652-983188A2-D626-4DEA-A9BC-998589868867Q37592617-22B9AB1D-A1E5-4CA0-BBA3-C4AB9D205237Q37607969-2008C291-7BB9-40A8-9B54-1D3CF45DBD24
P2860
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Meta-analysis of the associati ...... e to neoadjuvant chemotherapy.
@en
Meta-analysis of the associati ...... e to neoadjuvant chemotherapy.
@nl
type
label
Meta-analysis of the associati ...... e to neoadjuvant chemotherapy.
@en
Meta-analysis of the associati ...... e to neoadjuvant chemotherapy.
@nl
prefLabel
Meta-analysis of the associati ...... e to neoadjuvant chemotherapy.
@en
Meta-analysis of the associati ...... e to neoadjuvant chemotherapy.
@nl
P2093
P1476
Meta-analysis of the associati ...... e to neoadjuvant chemotherapy.
@en
P2093
Eleftherios Mamounas
Gunter von Minckwitz
Michael L Marinovich
P304
P356
10.1016/J.EJCA.2012.05.023
P577
2012-07-03T00:00:00Z